- Title: Subtitle
- SS1-2 SIGIRR protein suppresses Th17 cell proliferation via negative regulation of the Interleukin-1 receptor pathway and inhibition of mTOR kinase activation
- Creators
- Muhammet F Gulen - Cleveland ClinicZizhen Kang - Cleveland ClinicKatarzyna Bulek - Cleveland ClinicWan Youzhong - Cleveland ClinicTae Whan Kim - Cleveland ClinicYi Chen - Merck Research Laboratories (Schering-Plough Biopharma), 901 California Avenue, Palo Alto, CA 94304, USACengiz Z Altuntas - Cleveland ClinicKristian Sass Bak-Jensen - Merck Research Laboratories (Schering-Plough Biopharma), 901 California Avenue, Palo Alto, CA 94304, USAMandy J McGeachy - Merck Research Laboratories (Schering-Plough Biopharma), 901 California Avenue, Palo Alto, CA 94304, USAJeong-Su Do - Cleveland ClinicHui Xiao - Cleveland ClinicGreg M Delgoffe - Sidney Kimmel Comprehensive Cancer CenterBooki Min - Cleveland ClinicJonathan D Powell - Sidney Kimmel Comprehensive Cancer CenterVincent K Tuohy - Cleveland ClinicDaniel J Cua - Merck Research Laboratories (Schering-Plough Biopharma), 901 California Avenue, Palo Alto, CA 94304, USAXiaoxia Li - Cleveland Clinic
- Resource Type
- Abstract
- Publication Details
- Cytokine (Philadelphia, Pa.), Vol.52(1-2), pp.11-11
- DOI
- 10.1016/j.cyto.2010.07.049
- ISSN
- 1043-4666
- eISSN
- 1096-0023
- Publisher
- Elsevier Ltd
- Language
- English
- Date published
- 10/2010
- Academic Unit
- Pathology; Iowa Neuroscience Institute
- Record Identifier
- 9984201117702771
Abstract
SS1-2 SIGIRR protein suppresses Th17 cell proliferation via negative regulation of the Interleukin-1 receptor pathway and inhibition of mTOR kinase activation
Cytokine (Philadelphia, Pa.), Vol.52(1-2), pp.11-11
10/2010
DOI: 10.1016/j.cyto.2010.07.049
Details
Metrics
14 Record Views